PHGUF
Price
$1.50
Change
+$0.13 (+9.49%)
Updated
Sep 5 closing price
Capitalization
1.02B
PRRUF
Price
$0.19
Change
-$0.02 (-9.52%)
Updated
May 29 closing price
Capitalization
225.74M
Interact to see
Advertisement

PHGUF vs PRRUF

Header iconPHGUF vs PRRUF Comparison
Open Charts PHGUF vs PRRUFBanner chart's image
Pharming Group
Price$1.50
Change+$0.13 (+9.49%)
Volume$2.13K
Capitalization1.02B
Immutep
Price$0.19
Change-$0.02 (-9.52%)
Volume$600
Capitalization225.74M
PHGUF vs PRRUF Comparison Chart in %
Loading...
PHGUF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRRUF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PHGUF vs. PRRUF commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PHGUF is a Buy and PRRUF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (PHGUF: $1.50 vs. PRRUF: $0.19)
Brand notoriety: PHGUF and PRRUF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PHGUF: 119% vs. PRRUF: 100%
Market capitalization -- PHGUF: $1.02B vs. PRRUF: $225.74M
PHGUF [@Biotechnology] is valued at $1.02B. PRRUF’s [@Biotechnology] market capitalization is $225.74M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PHGUF’s FA Score shows that 1 FA rating(s) are green whilePRRUF’s FA Score has 0 green FA rating(s).

  • PHGUF’s FA Score: 1 green, 4 red.
  • PRRUF’s FA Score: 0 green, 5 red.
According to our system of comparison, PHGUF is a better buy in the long-term than PRRUF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PHGUF’s TA Score shows that 3 TA indicator(s) are bullish while PRRUF’s TA Score has 2 bullish TA indicator(s).

  • PHGUF’s TA Score: 3 bullish, 3 bearish.
  • PRRUF’s TA Score: 2 bullish, 0 bearish.
According to our system of comparison, PRRUF is a better buy in the short-term than PHGUF.

Price Growth

PHGUF (@Biotechnology) experienced а +15.38% price change this week, while PRRUF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.48%, and the average quarterly price growth was +31.71%.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PHGUF($1.02B) has a higher market cap than PRRUF($226M). PHGUF YTD gains are higher at: 52.827 vs. PRRUF (-4.879). PHGUF has higher annual earnings (EBITDA): 29.5M vs. PRRUF (-43.83M). PRRUF has more cash in the bank: 159M vs. PHGUF (126M). PRRUF has less debt than PHGUF: PRRUF (1.69M) vs PHGUF (128M). PHGUF has higher revenues than PRRUF: PHGUF (340M) vs PRRUF (0).
PHGUFPRRUFPHGUF / PRRUF
Capitalization1.02B226M450%
EBITDA29.5M-43.83M-67%
Gain YTD52.827-4.879-1,083%
P/E RatioN/AN/A-
Revenue340M0-
Total Cash126M159M79%
Total Debt128M1.69M7,596%
FUNDAMENTALS RATINGS
PHGUF vs PRRUF: Fundamental Ratings
PHGUF
PRRUF
OUTLOOK RATING
1..100
4637
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
84
Overvalued
PROFIT vs RISK RATING
1..100
8885
SMR RATING
1..100
9396
PRICE GROWTH RATING
1..100
3874
P/E GROWTH RATING
1..100
12100
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PHGUF's Valuation (76) in the null industry is in the same range as PRRUF (84). This means that PHGUF’s stock grew similarly to PRRUF’s over the last 12 months.

PRRUF's Profit vs Risk Rating (85) in the null industry is in the same range as PHGUF (88). This means that PRRUF’s stock grew similarly to PHGUF’s over the last 12 months.

PHGUF's SMR Rating (93) in the null industry is in the same range as PRRUF (96). This means that PHGUF’s stock grew similarly to PRRUF’s over the last 12 months.

PHGUF's Price Growth Rating (38) in the null industry is somewhat better than the same rating for PRRUF (74). This means that PHGUF’s stock grew somewhat faster than PRRUF’s over the last 12 months.

PHGUF's P/E Growth Rating (12) in the null industry is significantly better than the same rating for PRRUF (100). This means that PHGUF’s stock grew significantly faster than PRRUF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PHGUFPRRUF
RSI
ODDS (%)
Bearish Trend 1 day ago
64%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
66%
N/A
Momentum
ODDS (%)
Bullish Trend 1 day ago
40%
N/A
MACD
ODDS (%)
Bullish Trend 1 day ago
39%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
41%
Bullish Trend 1 day ago
53%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
40%
Bullish Trend 1 day ago
51%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
54%
N/A
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
PHGUF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRRUF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IVVYX24.960.18
+0.73%
Macquarie International Core Eq Y
PICEX7.23N/A
N/A
Virtus SGA Emerging Markets Equity C
PGUCX15.61N/A
N/A
Virtus Duff & Phelps Global Infras C
GOGIX33.06N/A
N/A
JHancock International Growth I
LVPSX96.73N/A
N/A
ProFunds Large Cap Value Svc

PHGUF and

Correlation & Price change

A.I.dvisor tells us that PHGUF and DRUG have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PHGUF and DRUG's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHGUF
1D Price
Change %
PHGUF100%
+9.49%
DRUG - PHGUF
28%
Poorly correlated
-3.89%
CGTX - PHGUF
25%
Poorly correlated
+0.77%
IMMP - PHGUF
23%
Poorly correlated
+1.85%
XFOR - PHGUF
23%
Poorly correlated
-3.85%
TVGN - PHGUF
22%
Poorly correlated
-1.47%
More

PRRUF and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRRUF has been loosely correlated with IMMP. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if PRRUF jumps, then IMMP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRRUF
1D Price
Change %
PRRUF100%
N/A
IMMP - PRRUF
43%
Loosely correlated
+1.85%
CALC - PRRUF
24%
Poorly correlated
-2.84%
PHGUF - PRRUF
21%
Poorly correlated
+9.49%
PVCT - PRRUF
11%
Poorly correlated
-1.14%
OXBDF - PRRUF
9%
Poorly correlated
N/A
More